Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06807294

Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
21 (estimated)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research is being done to determine whether a 12-week virtual Tai Chi training program, designed to improve balance and small nerve fiber function, is feasible and acceptable among cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN).

Detailed description

This is a prospective, randomized, waitlist-controlled pilot trial to examine the suitability of the virtual Tai Chi program in cancer survivors with CIPN. Tai Chi is a mind-body practice that involves gentle body movements, meditation, and breathing techniques. It has proven to be effective in enhancing balance control and relieving musculoskeletal pains. This study randomly assigns cancer survivors with CIPN with self-perceived balance difficulties to one of two groups: Group A Tai Chi Group versus Group B Waitlist Group. Randomization means a participant is placed into a study group by chance. The research study procedures including screening for eligibility, questionnaires, and sensory and functional testing. Participation in this study is expected to last for up to 12 weeks. It is expected that about 21 people will take part in this research study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTai Chi Program12-week virtual Tai Chi program with experienced Tai Chi instructor. Sessions will be conducted via the HIPPA-compliant teleconference platform, Zoom.

Timeline

Start date
2026-01-16
Primary completion
2026-08-31
Completion
2026-10-31
First posted
2025-02-04
Last updated
2026-01-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06807294. Inclusion in this directory is not an endorsement.